Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Boehringer Ingelheim
Merck
Mallinckrodt
McKinsey

Predict the Future

Your single source for accurate, objective, and timely intelligence

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

→ See why others have switched

Say
Say 'NO' to Bad Contracts

Are you tired of having to navigate complicated contracts?

Let DrugPatentWatch free you…

Anticipate Generic Drug Launch
Stop Guessing!

Will a generic version of a drug launch? And when?

Expert analysis based on objective data.

Automated Reports
Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?

DrugPatentWatch can take the load off of your team.

What our Clients Say

 I've been using DPW for years and I'm grateful for the responsiveness of the owner, Yali Friedman 

Individual Researcher

Automated Reports

Automated Reports & Custom Dashboards

  • Do more with less staff
  • Take the load off your team
  • Automate processes and focus on growing your business
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track drugs in development and explore new indications for existing drugs
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Track 505(b)(2) entrants

Monitor 505(b)(2) and biosimilar activity

  • Anticipate 505(b)(2) and biosimilar approvals
  • Track OTC-switches, new formulations, biosimilars, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Merck
Johnson and Johnson
Moodys